Is POVIDONE K30 Safe? — Ingredient Safety Profile · Greenveil
Ingredients POVIDONE K30 beauty / cleaning / food / industrial / pharma
POVIDONE K30 EPA CPDat observed this chemical in 1957 composition records across product categories including Specialty occupational products, Raw materials, Food and drug.
Research docs 0 Claims 0 Sources 135 Function anti-irritant • Anti-static agent Identifier DTXSID0025941 5
Concern score
5/100 Low concern based on regulatory listings.
How we scored this The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Where it appears Prevalence of POVIDONE K30 in our catalog (epa_cpdat).
Specialty occupational products Raw materials Food and drug Laboratory supplies Arts and crafts/office supplies Pet and animal care
Typical roles
anti-irritant Anti-static agent Binder Dispersing agent Emulsifier
Catalog
Found in these products 33 products Suitability Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Linked research Primary documents currently linked to this ingredient record.
No linked research documents are attached to this ingredient yet.
Extracted claims Structured claim signals pulled from linked ingredient research.
No extracted claims are attached to this ingredient yet.
Regulatory status Published jurisdiction-level classifications and regulatory designations for this ingredient.
EPA CPDat observed this chemical in 1957 composition records across product categories including Specialty occupational products, Raw materials, Food and drug. EPA CPDat classifies this chemical for functional uses including anti-irritant, Film former, Anti-static agent.
inactive ingredient database Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: NA
inactive ingredient database Film former
Fixing agent (mordant)
Fragrance
Gillette G
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
Evidence read The published evidence profile currently shaping this ingredient record.
No evidence profiles are attached to this ingredient yet.
Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 0.2 %w/v
inactive ingredient database Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 1.8 %w/v
inactive ingredient database Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 1.8 %w/v
inactive ingredient database Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 0.6 %w/v
inactive ingredient database Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 300 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 10.03 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Potency: NA
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Potency: NA
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE PELLETS; Maximum daily exposure: 32 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 56 mg
inactive ingredient database Route: ORAL; Dosage form: DROPS; Potency: NA
inactive ingredient database Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION, EXTENDED RELEASE; Potency: NA
inactive ingredient database Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: 35 mg/5ml
inactive ingredient database Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 3000 mg
inactive ingredient database Route: ORAL; Dosage form: SUSPENSION; Potency: 20 mg/5ml
inactive ingredient database Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 216 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 48 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, COATED; Potency: 49.2 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 53 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 101 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 240 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Potency: 17 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Potency: 2 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Potency: 15.03 mg
inactive ingredient database Route: ORAL; Dosage form: TROCHE; Potency: 30 mg
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: IMPLANT; Potency: 6 mg
inactive ingredient database Route: SUBLINGUAL; Dosage form: TABLET; Potency: 6 mg
inactive ingredient database Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 41 mg
inactive ingredient database Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Potency: NA
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 648 mg
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 0.2 %w/v
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 600 mg
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION; Potency: 0.08 %w/v
inactive ingredient database Route: INTRAVENOUS; Dosage form: SOLUTION, CONCENTRATE; Maximum daily exposure: 1000 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 173 mg
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 20 mg
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 20 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE; Potency: 130 mg
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION; Potency: 0.5 %w/v
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: SUSPENSION; Potency: 0.5 %w/v
inactive ingredient database Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 200 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 90 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 67 mg
inactive ingredient database Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Potency: 0.27 mg
inactive ingredient database Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 126 mg
inactive ingredient database Route: ORAL; Dosage form: SOLUTION; Potency: 500 mg/5ml
inactive ingredient database Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 640 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 0.45 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 240 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 49 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 200 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 163 mg
inactive ingredient database Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 1 mg
inactive ingredient database Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 0.59 %w/v
inactive ingredient database Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 42 mg
inactive ingredient database Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 4 mg
inactive ingredient database Route: OPHTHALMIC; Dosage form: SUSPENSION; Maximum daily exposure: 14 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 540 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Maximum daily exposure: 15 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 227 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE PELLETS; Maximum daily exposure: 178 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 120 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 101 mg
inactive ingredient database Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 202 mg
inactive ingredient database Route: ORAL; Dosage form: GRANULE, EFFERVESCENT; Potency: 40 mg
inactive ingredient database Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 120 mg
inactive ingredient database Route: ORAL; Dosage form: LOZENGE; Maximum daily exposure: 700 mg
inactive ingredient database Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 24 mg
inactive ingredient database Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 378 mg
inactive ingredient database Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 2832 mg
inactive ingredient database Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 257 mg
inactive ingredient database Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 300 mg
inactive ingredient database Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 148 mg
inactive ingredient database Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 474 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 2828 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 245 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 12 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 160 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 516 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, DELAYED RELEASE PARTICLES; Maximum daily exposure: 70 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 368 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 245 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Potency: 45 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 462 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 71 mg
inactive ingredient database Route: ORAL; Dosage form: TROCHE; Maximum daily exposure: 175 mg
inactive ingredient database Route: SUBLINGUAL; Dosage form: FILM; Maximum daily exposure: 7 mg
inactive ingredient database Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 30 mg
inactive ingredient database Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 1.9 %w/w
inactive ingredient database Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Maximum daily exposure: 16 mg
inactive ingredient database Route: TRANSDERMAL; Dosage form: SYSTEM; Maximum daily exposure: 15 mg
inactive ingredient database Route: VAGINAL; Dosage form: INSERT; Maximum daily exposure: 147 mg
inactive ingredient database Route: AURICULAR (OTIC); Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 2 mg
inactive ingredient database Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.3 %w/v
inactive ingredient database Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 1.2 %w/w
inactive ingredient database Route: OPHTHALMIC; Dosage form: SUSPENSION; Maximum daily exposure: 4 mg
inactive ingredient database Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 1.5 %w/v
inactive ingredient database Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 270 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 137 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 118 mg
inactive ingredient database Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 140 mg
inactive ingredient database Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 2 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 966 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, COATED; Potency: 9.77 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 192 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 498 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 128 mg
inactive ingredient database Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 120 mg
inactive ingredient database Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 280 mg
inactive ingredient database Route: TRANSDERMAL; Dosage form: SOLUTION; Maximum daily exposure: 100 mg
inactive ingredient database Route: TRANSDERMAL; Dosage form: SYSTEM; Potency: 20 mg
FDA NDC lists this ingredient in 53 active drug products and 54 total products.
listed in openFDA substance openFDA substance registry classifies this ingredient as polymer.
listed in openFDA substance openFDA substance registry classifies this ingredient as mixture.
